These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy. Jamroziak K; Tadmor T; Robak T; Polliack A Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923 [TBL] [Abstract][Full Text] [Related]
11. Disseminated histoplasmosis as pseudo Richter's transformation in a patient with chronic lymphocytic leukemia. Jain P; Hu S; Jabbour E; Takahashi K; Pemmaraju N; O'Brien S; Mulanovich VE; Estrov Z Am J Hematol; 2015 Aug; 90(8):752-3. PubMed ID: 25850565 [No Abstract] [Full Text] [Related]
12. Ibrutinib treatment via alternative administration in a patient with chronic lymphocytic leukemia and dysphagia. DiSogra KY; Tran T; Arnall JR; Janes A; Moore DC; Park SI J Oncol Pharm Pract; 2021 Jul; 27(5):1265-1269. PubMed ID: 33106104 [TBL] [Abstract][Full Text] [Related]
13. Richter transformation of chronic lymphocytic leukemia into composite diffuse large B-cell and Hodgkin lymphoma. Michelis FV; Kourti G; Skertsou M; Karmiris T; Rontogianni DP; Harhalakis N Leuk Lymphoma; 2012 Nov; 53(11):2302-3. PubMed ID: 22432520 [No Abstract] [Full Text] [Related]
14. Cutaneous Richter Syndrome Mimicking Primary Cutaneous CD4-Positive Small/Medium T-cell Lymphoma: Case Report and Review of the Literature. Rito M; Cabeçadas J; Costa Rosa J; Cravo M; Robson A Am J Dermatopathol; 2018 Apr; 40(4):286-290. PubMed ID: 28937430 [TBL] [Abstract][Full Text] [Related]
15. Central nervous system immune reconstitution inflammatory syndrome after ibrutinib therapy for Richter transformation. Chan KL; Lokan J; Tam CS; Lew TE; Prince HM Leuk Lymphoma; 2017 Jan; 58(1):207-210. PubMed ID: 27326828 [No Abstract] [Full Text] [Related]
16. Case study interpretation-New Orleans: case 4. Richter syndrome characterized by diffuse large B cell lymphoma in the context of prior chronic lymphocytic leukemia/small lymphocytic lymphoma. Linden MA Cytometry B Clin Cytom; 2013; 84(5):350-3. PubMed ID: 23283841 [No Abstract] [Full Text] [Related]
17. BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma. Fiskus W; Mill CP; Perera D; Birdwell C; Deng Q; Yang H; Lara BH; Jain N; Burger J; Ferrajoli A; Davis JA; Saenz DT; Jin W; Coarfa C; Crews CM; Green MR; Khoury JD; Bhalla KN Leukemia; 2021 Sep; 35(9):2621-2634. PubMed ID: 33654205 [TBL] [Abstract][Full Text] [Related]
18. Transformation to plasmablastic lymphoma in CLL upon ibrutinib treatment. Marvyin K; Tjønnfjord EB; Breland UM; Tjønnfjord GE BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32994268 [TBL] [Abstract][Full Text] [Related]
19. Prognostic models in chronic lymphocytic leukemia patients receiving ibrutinib therapy: Results of a comparative performance analysis. Molica S; Baumann T; Giannarelli D Eur J Haematol; 2021 Mar; 106(3):425-427. PubMed ID: 33190324 [No Abstract] [Full Text] [Related]
20. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma. Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]